Drug Utilization Review (DUR) Board

Drug Utilization Review (DUR) is designed to improve the quality of pharmaceutical care by ensuring that prescriptions are appropriate, medically necessary and unlikely to result in adverse medical outcomes. Medicaid’s DUR program includes prospective, online and retrospective review as well as use of standards developed by the National Council for Prescription Drug Programs (NCPDP). A board comprised of physicians and pharmacists provides guidance to Agency staff.

About the Board   Board Meetings  

Alabama Medicaid DUR Board Meeting, July 28, 2021: As the Alabama State of Emergency has been lifted, the July 28, 2021 DUR Board meeting will be held in person at the Alabama Medicaid building in Montgomery, Alabama. Voting members must be present to count toward a quorum. A virtual WebEx option will be available on the Medicaid website for the public to attend/observe the meeting. All meetings of this Committee are open to the public. CLICK HERE for the virtual WebEx option.

DUR Board Minutes 2016-2021